Bioporto A/S Eulerpool Vijesti

Bioporto A/S Eulerpool News

Bioporto A/S Aktie News

Bioporto A/S prate mnogi novinari i investitori širom svijeta. Najnovije Bioporto A/S vijesti prikupljamo ovdje.

• 26. srpnja ·

  Yahoo
  BioPorto to Debut FDA Approved ProNephro AKI at Upcoming ADLM 2024 Clinical Lab Expo
• 17. srpnja ·

  Yahoo
  Preliminary data suggests potential use beyond early AKI diagnosis for NGAL biomarker
• 11. srpnja ·

  Yahoo
  Results from Clinical Studies Highlight the Efficacy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Predicting Acute Kidney Injury
• 4. srpnja ·

  Yahoo
  Grant of Warrants
• 1. srpnja ·

  Yahoo
  BioPorto confirms market acceptance of NGAL products with US standing order.
• 24. lipnja ·

  Yahoo
  Managers’ transactions
• 24. lipnja ·

  Yahoo
  Changes of number of shares and votes in BioPorto A/S
• 18. lipnja ·

  Yahoo
  Private placement of 50,000,000 new shares oversubscribed - gross proceeds of DKK 81.4 million, corresponding to USD 11.7 million, to BioPorto A/S.
• 17. lipnja ·

  Yahoo
  BioPorto A/S initiates a private placement of 50,000,000 new shares at market price.
• 30. svibnja ·

  Yahoo
  BioPorto A/S Appoints Chief Financial Officer